Biotech, Bank Raise Combined $276M In Low-Priced IPOs
Drug developer Vir Biotechnology Inc. and Chicago-area bank HBT Financial Inc. made their debuts in public markets Friday after raising nearly $276 million combined in initial public offerings that priced at...To view the full article, register now.
Already a subscriber? Click here to view full article